 "Abbott India Q3 net up marginally at Rs 117 cr, revenue rises to Rs 947 cr")
Drug firm Abbott India on Friday reported a marginal rise of 1.43 per cent in its net profit to Rs 117.05 crore for the third quarter ended December 31, 2018.
The company had posted a net profit of Rs 115.39 crore for the corresponding period of the previous financial year, Abbott India said in a filing to BSE.
Revenue from operations of the company stood at Rs 947.65 crore for the quarter under consideration, as against Rs 881.49 crore for the same period year ago.
Shares of Abbott India closed at Rs 8,062.40 per scrip on BSE, down 2.23 per cent from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app